These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12658947)

  • 21. Comparison between sevoflurane and propofol neuromuscular effects in a patient with myasthenia gravis: effective doses of vecuronium.
    Itoh H; Shibata K
    Anesthesiology; 2001 Sep; 95(3):803-5. PubMed ID: 11575561
    [No Abstract]   [Full Text] [Related]  

  • 22. Recovery properties of cisatracurium and vecuronium in intensive care unit patients.
    Fuchs-Buder T; Suter PM
    Anesth Analg; 1996 Apr; 82(4):892-3. PubMed ID: 8615532
    [No Abstract]   [Full Text] [Related]  

  • 23. Vecuronium neuromuscular block in a patient with Charcot-Marie-Tooth syndrome.
    Baraka AS
    Anesth Analg; 1997 Apr; 84(4):927-8. PubMed ID: 9085985
    [No Abstract]   [Full Text] [Related]  

  • 24. Interaction of aminoglycoside antibiotics with steroidnon-depolarizing muscle relaxant agents.
    Giala M; Crassaris L; Papadakis E; Pangalis A; Zachariades B; Paradelis AG
    J Chemother; 1989 Jul; 1(4 Suppl):622-3. PubMed ID: 16312561
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of atracurium and vecuronium at the carotid body.
    Kopman AF
    Acta Anaesthesiol Scand; 2003 Apr; 47(4):494; author reply 494-5. PubMed ID: 12694157
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of a PID controller to model vecuronium pharmacokinetics and pharmacodynamics during liver transplantation. Proportional-integral-derivative.
    O'Hara DA; Hexem JG; Derbyshire GJ; Overdyk FJ; Chen B; Henthorn TK; Li KJ
    IEEE Trans Biomed Eng; 1997 Jul; 44(7):610-9. PubMed ID: 9210821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of pancuronium and vecuronium for fetal neuromuscular blockade during invasive procedures.
    Watson WJ; Atchison SR; Harlass FE
    J Matern Fetal Med; 1996; 5(3):151-4. PubMed ID: 8796786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of neonatal status after use of vecuronium as a muscle relaxant in caesarean section.
    Das S; Bhattacharjee M; Maitra S
    J Indian Med Assoc; 1993 Mar; 91(3):54-6. PubMed ID: 8102387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Autocontrol of muscle relaxation with vecuronium].
    Sibilla C; Zatelli R; Marchi M; Zago M
    Minerva Anestesiol; 1990; 56(1-2):33-8. PubMed ID: 1977105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative residual curarization and evidence-based anaesthesia.
    Viby-Mogensen J
    Br J Anaesth; 2000 Mar; 84(3):301-3. PubMed ID: 10793585
    [No Abstract]   [Full Text] [Related]  

  • 32. Prolonged relaxant effects of vecuronium in patients with deliberate hypermagnesemia: time for caution in cesarean section.
    Yoshida A; Itoh Y; Nagaya K; Takino K; Sugawara J; Murakami T; Okamura K; Takahashi M
    J Anesth; 2006; 20(1):33-5. PubMed ID: 16421674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and pharmacodynamics of vecuronium in rats with systemic inflammatory response syndrome: treatment with NG-monomethyl-L-arginine.
    Blobner M; Kochs E; Fink H; Mayer B; Veihelmann A; Brill T; Stadler J
    Anesthesiology; 1999 Oct; 91(4):999-1005. PubMed ID: 10519503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of the neuromuscular blockade levels on amplitudes of posttetanic motor-evoked potentials and movement in response to transcranial stimulation in patients receiving propofol and fentanyl anesthesia.
    Yamamoto Y; Kawaguchi M; Hayashi H; Horiuchi T; Inoue S; Nakase H; Sakaki T; Furuya H
    Anesth Analg; 2008 Mar; 106(3):930-4, table of contents. PubMed ID: 18292442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid onset/offset of rapacuronium bromide explained?
    Proost JH; Schiere S; Beaufort TM; Wierda JM
    Anesthesiology; 1999 Nov; 91(5):1554-5; author reply 1555-6. PubMed ID: 10551617
    [No Abstract]   [Full Text] [Related]  

  • 36. The pharmacoeconomics of neuromuscular blocking drugs.
    Chiu JW; White PF
    Anesth Analg; 2000 May; 90(5 Suppl):S19-S23. PubMed ID: 10809514
    [No Abstract]   [Full Text] [Related]  

  • 37. Effective doses of vecuronium in a patient with myotonic dystrophy.
    Nishi M; Itoh H; Tsubokawa T; Taniguchi T; Yamamoto K
    Anaesthesia; 2004 Dec; 59(12):1216-8. PubMed ID: 15549982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapacuronium. Introduction.
    Bevan DR
    Anesth Analg; 2000 May; 90(5 Suppl):S1. PubMed ID: 10809510
    [No Abstract]   [Full Text] [Related]  

  • 39. [Muscle relaxation in Emery-Dreifuss muscular dystrophy].
    Moncho JM; Roigé J; Nadal M; Saludes J; Cabarrocas E
    Rev Esp Anestesiol Reanim; 1995 Nov; 42(9):403. PubMed ID: 8584784
    [No Abstract]   [Full Text] [Related]  

  • 40. [Search for new antidepolarizing muscle relaxants and the 1st experience with their clinical use].
    Vanevskiĭ VL; Danilov AF; Kotomina GL; Malygin VV; Starshinova LA
    Anesteziol Reanimatol; 1978; (4):36-8. PubMed ID: 151518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.